Please use this identifier to cite or link to this item:
http://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/1261
Title: | Nanoparticles of two ZnO Precursors as an Encapsulating Matrix of Mangiferin: Associated Studies to Cytotoxic Effects on Liver Cancer Cells Hep-G2 and Healthy Lung Cell Beas-2B |
Authors: | Razura Carmona, Francisco Fabián Herrera Martínez, Mayra Sáyago Ayerdi, Sonia G. Pérez Larios, Alejandro Montalvo González, Efigenia Ramírez Mares, Marco Vinicio Sánchez Burgos, Jorge Alberto |
Keywords: | ZnO precursors mangiferin anticiclooxigenase antitopoisomerase and toxicity |
Issue Date: | Jan-2022 |
Publisher: | Springer Nature |
Citation: | Razura-Carmona, F.F., Herrera-Martínez, M., Sáyago-Ayerdi, S.G. et al. Nanoparticles of two ZnO Precursors as an Encapsulating Matrix of Mangiferin: Associated Studies to Cytotoxic Effects on Liver Cancer Cells Hep-G2 and Healthy Lung Cell Beas-2B. J Clust Sci 33, 163–171 (2022). https://doi.org/10.1007/s10876-020-01957-7 |
Series/Report no.: | Journal of Cluster Science;Volume 33, issue 1 January 2022 |
Abstract: | Abstract In recent years, metal oxides have been studied as an encapsulating matrix nevertheless, few studies the effect that can exist between different precursors to form this type of nanomaterials; In this paper, we compare its ability as a mangiferin (MG) nanoencapsulated. Phytochemical that has been studied for its generous biological properties like anti-inflammatory, antiproliferative, and others; the nanoparticles (NP’s) be synthesized with zinc nitrate and zinc acetate. The results showed modifications in the morphology of the ZnO associated with the precursor but, there is no significant difference between any treatment that is associated with antitopoisomerase activity however, ZnOA-MG is statistically the best treatment by reducing in greater proportion the production of COX-II prostaglandins (97.38 ± 7.09%) with a significant difference (p < 0.05) compared toCOX-I (68.02 ± 2.14%) but, it is not considered a selective treatment moreover ZnOA-MG proved to be the least hepatotoxic (IC50, 140.19 ± 13.10 µg/mL) while ZnON is the most cytotoxic for HEP-G2 and BEAS-2B (IC50, 51.27 ± 4.72 and 26.91 ± 3.21 µg/mL). All treatments change the morphology of erythrocytes to low concentrations (25 µg/mL). Therefore the MG load benefits the biological impact of ZnO. |
Description: | Artículo |
URI: | http://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/1261 |
ISSN: | 1572-8862 online 1040-7278 print |
Appears in Collections: | 2414 Artículos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Nanoparticles of two ZnO Precursors as an Encapsulating Matrix.pdf | Documento | 1 MB | Adobe PDF | View/Open |
Enlace a_Nanoparticles of two ZnO Precursors as an Encapsulating Matrix.htm | Enlace a publicación | 48.42 kB | HTML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.